S16 / Operate

PM · bioequivalence trials.

Project management for BE studies. Clinical phase, bioanalytical phase, biostatistical phase. Sponsor-side oversight.

4 min read

You'll leave with: Why M13A-aligned BE study design needs sponsor-side rigor — particularly for India-EU bridge studies.

/ Who this is for

The fit.

Generic sponsors targeting US, EU, or India. Indian CROs needing sponsor-side liaison for cross-cultural project work.

/ The work itself

What this delivers.

Sponsor-side BE study PM. M13A-aligned design. Clinical, bioanalytical, biostatistical coordination.

/ Why this matters

Where the edge is.

Sponsor-side rigour. M13A-specific design depth. Cross-cultural India-EU mediator role — where most PMs operate single-region.

/ How engagement runs

The shape of the work.

Every engagement is scoped per situation. The shape — focused diagnostic, structured implementation, ongoing partnership — emerges from the discovery conversation rather than a fixed package. Some engagements are short and intense; some are months-long structural builds; some are recurring quality oversight. We talk first, then scope.

Discovery.

Confirm BE study scope and target market.

Scoping.

Per-study proposal.

Manage.

PM through clinical, bioanalytical, biostatistical phases.

Closeout.

Submission-ready package, lessons learned.

What to do next.

If this is the work in front of you, the next step is a conversation. I read every message and respond personally. No contact forms. No sales sequence. Just a discovery conversation to understand whether the fit is real, and what the shape of the work would be.

Cadence promise: I publish weekly on regulated AI governance. If a week is missed, the journal entry explaining why goes up in real-time.

DM on LinkedIn → Email → Browse all collaboration shapes →